Abstract
We have previously shown that expression of the papillomavirus E2 protein in HeLa cells induces p53 accumulation and causes both cell cycle arrest and apoptosis. In contrast to growth arrest, onset of apoptosis was not correlated with an increase of p53 transcriptional activity. In the present study, we conducted biochemical and genetic experiments in order to determine whether E2-induced apoptosis was independent of p53 induction. We showed that E2 did not alter the transcription of Bax, a known p53-activated cell death inducer. The time course of apoptotic cell death preceded p53 induction by several hours. Overexpression of the HPV18 E6 oncogene prevented E2-mediated p53 accumulation, but did not alter the rate of cell death. Finally, point mutants of the HPV18 E2 transactivation domain induced apoptosis, although they were unable to induce high p53 accumulation or cell cycle arrest. In addition, the results obtained with these mutants indicated that both transcriptional activation and replication functions of E2 were dispensable for the induction of cell death. These observations show that E2-induced apoptosis is an early event, independent of p53 accumulation and unrelated to downstream p53-dependent transcriptional events.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allday MJ, Inman GJ, Crawford DH and Farrell PJ. . 1995 EMBO J. 14: 4994–5005.
Benson JD and Howley PM. . 1995 J. Virol. 69: 4364–4372.
Benson JD, Lawande R and Howley PM. . 1997 J. Virol. 71: 8041–8047.
Berumen J, Casas L, Segura E, Amezcua J and Garcia-Carranca A. . 1994 Int. J. Cancer 56: 640–645.
Bissonnette N, Wasylyk B and Hunting DJ. . 1997 Biochem. Cell Biol. 75: 351–358.
Breiding DE, Sverdrup F, Grossel MJ, Moscufo N, Boonchai W and Androphy EJ. . 1997 Mol. Cell. Biol. 17: 7208–7219.
DeGregori J, Leone G, Miron A, Jakoi L and Nevins JR. . 1997 Proc. Natl. Acad. Sci. USA 94: 7245–7250.
Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC and Pierotti MA. . 1997 Oncogene 14: 2137–2147.
Demeret C, Yaniv M and Thierry F. . 1994 J. Virol. 68: 7075–7082.
Demeret C, Le Moal M, Yaniv M and Thierry F. . 1995 Nucl. Acids Res. 23: 4777–4784.
Demeret C, Desaintes C, Yaniv M and Thierry F. . 1997 J. Virol. 71: 9343–9349.
Desaintes C, Demeret C, Goyat S, Yaniv M and Thierry F. . 1997 EMBO J. 16: 504–514.
Donaldson KL, Goolsby GL and Wahl AF. . 1994 Int. J. Cancer 57: 847–855.
Dong G, Broker TR and Chow LT. . 1994 J. Virol. 68: 1115–1127.
Dostatni N, Lambert PF, Sousa R, Ham J, Howley PM and Yaniv M. . 1991 Genes Dev. 5: 1657–1671.
Dowhanick JJ, McBride AA and Howley PM. . 1995 J. Virol. 69: 7791–7799.
Dyson N, Howley PM, Münger K and Harlow E. . 1989 Science 243: 934–937.
El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.
Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH and Greenberg ME. . 1996 Cell 85: 549–561.
Fritsche M, Haessler C and Brandner G. . 1993 Oncogene 8: 307–318.
Fueyo J, Gomez-Manzano C, Yung WK, Liu TJ, Alemany R, McDonnell TJ, Shi X, Rao JS, Levin VA and Kyritsis AP. . 1998 Nature Med. 4: 685–690.
Goodwin EC, Naeger LK, Breiding DE, Androphy EJ and DiMaio D. . 1998 J. Virol. 72: 3925–3934.
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell CL and Swindell E. . 1995 Mol. Biol. Cell 6: 387–400.
Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. . 1995 Genes Dev. 9: 2170–2183.
Hegde RS, Grossman SR, Laimins LA and Sigler PB. . 1992 Nature 359: 505–512.
Hsieh JK, Fredersdorf S, Kouzarides T, Martin K and Lu X. . 1997 Genes Dev. 11: 1840–1852.
Hwang ES, Riese DJ, Settleman J, Nilson LA, Honig J, Flynn S and DiMaio D. . 1993 J. Virol. 67: 3720–3729.
Hwang E-S, Naeger LK and DiMaio D. . 1996 Oncogene 12: 795–803.
Le Moal MA, Yaniv M and Thierry F. . 1994 J. Virol. 68: 1085–1093.
Levine AJ. . 1997 Cell 88: 323–331.
Li R and Botchan MR. . 1993 Cell 73: 1207–1221.
Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G and Branton PE. . 1998 J. Virol. 72: 7144–7153.
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ and Baldwin Jr AS. . 1997 Science 278: 1812–1815.
McBride A and Myers G. . 1996 Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences Vol. III. Myers G, Baker K, Wheeler C, Halpern A, McBride A and Doorbar J . (eds). In: Theoretical Biology and Biophysics III Los Alamos pp15–32.
Miyashita T and Reed JC. . 1995 Cell 80: 293–299.
Phillips AC, Bates S, Ryan KM, Helin K and Vousden KH. . 1997 Genes Dev. 11: 1853–1863.
Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B. . 1996 Genes Dev. 10: 1945–1952.
Rank NM and Lambert PF. . 1995 J. Virol. 69: 6323–6334.
Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. . 1996 EMBO J. 15: 827–838.
Sakai H, Yasugi T, Benson JD, Dowhanick JJ and Howley P. . 1996 J. Virol. 70: 1602–1611.
Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. . 1990 Cell 63: 1129–1136.
Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H. . 1985 Nature 314: 111–114.
Steger G, Ham J, Lefebvre O and Yaniv M. . 1995 EMBO J. 14: 329–340.
Tan SH, Gloss B and Bernard HU. . 1992 Nucl. Acids Res. 20: 251–256.
Thierry F and Yaniv M. . 1987 EMBO J. 6: 3391–3397.
Thierry F, Dostatni N, Arnos F and Yaniv M. . 1990 Mol. Cell. Biol. 10: 4431–4437.
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. . 1993 Nature 366: 701–704.
Yao JM, Breiding DE and Androphy EJ. . 1998 J. Virol. 72: 1013–1019.
Acknowledgements
This work was supported by the ‘Association pour la Recherche contre le Cancer (ARC)’ and the ‘Ligue Française contre le Cancer’. We are very grateful to Jonathan Weitzman and Caroline Demeret for critical reading of the manuscript. We thank Martin Scheffner for the gift of HPV18 E6 expression plasmid and Moshe Oren for MDM2-CAT.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Desaintes, C., Goyat, S., Garbay, S. et al. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene 18, 4538–4545 (1999). https://doi.org/10.1038/sj.onc.1202818
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202818
Keywords
This article is cited by
-
A fully defined static suspension culture system for large-scale human embryonic stem cell production
Cell Death & Disease (2018)
-
Pentoxifylline attenuates HPV-16 associated necrosis in placental trophoblasts
Archives of Gynecology and Obstetrics (2015)
-
HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis
Molecular and Cellular Biochemistry (2014)
-
The modulation of apoptosis by oncogenic viruses
Virology Journal (2013)
-
The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes
Radiation Oncology (2012)